• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

New failed trials of intrathecal rituximab in PMS

July 9, 2021  

T25FW useful to identify early progression in MS

June 29, 2021  

COVID vaccination and anti-CD20s – an update

June 28, 2021  

Highlights from EAN 2021

June 22, 2021  

COVID-19 mortality in MS patients: a systematic review

June 1, 2021  

Anti-CD20 therapies – Mechanisms of action

May 25, 2021  

MS Clinics Network updates COVID vaccine guidance

May 3, 2021  

Are trial data generalizable to MS population?

April 27, 2021  

Few vaccine responders with fingolimod, ocrelizumab

April 23, 2021  

Early, effective MS treatment revisited

April 8, 2021  
Previous
13
14
15
16
17
Next

Browse by Topic

  • MS (414)
  • CLINICAL CASES IN MS (16)
  • EPILEPSY (36)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • DMT prescribing in Canada – survey results posted on June 6, 2025
  • CLINICAL CASES IN MS: A 42 Y.O. WOMAN WITH A SEVERE RELAPSE ON DMF posted on June 2, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions